Search filters

List of works by Yeon Hee Park

A phase II trial of the pan-HER inhibitor poziotinib, in patients with HER2-positive metastatic breast cancer who had received at least two prior HER2-directed regimens: results of the NOV120101-203 trial

scientific article published on 07 November 2018

Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome

scientific article published on 02 December 2020

Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib

scientific article published on 28 August 2020

Docetaxel plus epirubicin as first-line chemotherapy in MBC (KCSG 01-10-05): phase II trial and the predictive values of circulating HER2 extracellular domain and vascular endothelial growth factor.

scientific article published in August 2005

Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: result of an institution database from South Korea

scientific article published on 17 January 2019

Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11)

scientific article published on 12 August 2019

Genetic and Clinical Characteristics of Phyllodes Tumors of the Breast

scientific article published on 12 November 2017

Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type

scientific article published on 18 August 2005

Molecular alterations and poziotinib efficacy, a pan-HER inhibitor, in human epidermal growth factor receptor 2 (HER2)-positive breast cancers: Combined exploratory biomarker analysis from a phase II clinical trial of poziotinib for refractory HER2-

scientific article published on 27 February 2019

Pembrolizumab for Early Triple-Negative Breast Cancer

scientific article published on 01 February 2020

The Value of Ki67 in Very Young Women with Hormone Receptor-Positive Breast Cancer: Retrospective Analysis of 9,321 Korean Women

scientific article published on 05 February 2015

Validation and comparison of CS-IHC4 scores with a nomogram to predict recurrence in hormone receptor-positive breast cancers

scientific article published on 04 June 2014

Paulina is supported by:

About Paulina

Help